Journal of Clinical Epidemiology
Volume 63, Issue 2 , Pages 126-127 , February 2010

Pharmaceutical company–sponsored drug trials: what are we to believe?

,Accepted 31 July 2009.

References 

  1. Gartlehrner et al.
  2. Rochon PA, Gurwitz JH, Simms RW, Fortin PR, Felson DT, Minaker KL, et al. A study of manufacturer-supported trials of nonsteroidal anti-inflammatory drugs in the treatment of arthritis. Arch Intern Med. 1994;154:157–163
  3. Heres S, Davis J, Maino K, Jetzinger E, Kissling W, Leucht S. Why olanzapine beats risperidone, risperidone beats quetiapine, and quetiapine beats olanzapine: an exploratory analysis of head-to-head comparison studies of second generation anti-psychotics. Am J Psychiatry. 2006;163:185–194
  4. Gotzsche PZ. Methodology and overt and hidden bias in repots of 196 double blind trials on nonsteroidal anti-inflammatory drugs in rheumatoid arthritis. Control Clin Trials. 1989;10:31–56

PII: S0895-4356(09)00230-3

doi: 10.1016/j.jclinepi.2009.07.014

Journal of Clinical Epidemiology
Volume 63, Issue 2 , Pages 126-127 , February 2010

Article Tools